#POLB Poolbeg Pharma PLC – POLB 001 data to be presented at ASH November 6, 2024 – Posted in: Poolbeg Pharma (POLB)

6 November 2024 – Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, today announces that it will present a poster detailing POLB 001’s efficacy in reducing immunotherapy-induced CRS in an in vivo animal model, at the 66th American Society of Hematology (‘ASH’) Annual Meeting and Exposition, taking place 7-10 December 2024 in San Diego, California. Poolbeg’s poster presentation will provide insights into the results…

Continue reading